The goal of this project is to study the surface glycoproteins of the
African trypanosome, Trypanosoma brucei. VSG, the major surface protein
of bloodstream form parasites, protects subsurface structures from
recognition by the host immune system. Switching expression from one VSG
to another (antigenic variation) allows the parasite to survive in the
host's bloodstream. PARP (procyclic acidic repetitive protein) is an
unusual protein which overs the surface of the insect form of T. brucei.
Our studies focus mainly on the glycosyl groups of these proteins, with
most studies on the GPI anchor of VSG.
Since myristate is an important component of the VSG anchor, the first
specific aim will be to study the mechanism by which myristate is taken
up by the cell and processed. This is a problem for the parasite, as it
cannot synthesize myristate and it lives in an environment where this
fatty acid is in low concentration. In these studies we will purify and
characterize myristoyl-CoA synthases and we shall look for myristate
transporters and binding proteins. We shall use biochemical approaches
as well as yeast genetics to find these proteins or their genes. The
second specific aim will be to study GPI biosynthesis and catabolism,
with most emphasis placed on the mechanism of GPI myristoylation in
bloodstream forms. In the third specific aim we will characterize T.
brucei glycosylation mutants. We have already isolated mutants of the
procyclic stage of T. brucei, which have an altered PARP, and we are
studying whether the mutations affect N-linked glycosylation or the GPI
structure. We will attempt to clone the mutant gene by functional
complementation
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-May-1984
Project End Date
30-April-2002
Budget Start Date
01-May-2000
Budget End Date
30-April-2001
Project Funding Information for 2000
Total Funding
$328,669
Direct Costs
$202,882
Indirect Costs
$125,787
Year
Funding IC
FY Total Cost by IC
2000
National Institute of Allergy and Infectious Diseases
$328,669
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI021334-17
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI021334-17
Patents
No Patents information available for 5R01AI021334-17
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI021334-17
Clinical Studies
No Clinical Studies information available for 5R01AI021334-17
News and More
Related News Releases
No news release information available for 5R01AI021334-17
History
No Historical information available for 5R01AI021334-17
Similar Projects
No Similar Projects information available for 5R01AI021334-17